The Worldwide Tissue Microarray Market is expected to grow at a CAGR of 10.88% during the forecast period 2017-2023. Tissue microarray (TMA) is a recipient paraffin block that comprises thousands of separate tissue centers assembled in array fashion to allow multiplex histological analysis. These TMAs allow a quick, cost-effective, high through-put examination of thousands of molecular markers at nucleic acids or protein level. TMA is the latest advancement in the field of pathology. Different sorts of tumors at different phases of disease progression can also be studied at a single stage, in identical conditions in less labor-intensive and cost-effective ways.
The market for tissue microarray treatment is growing extensively. It is a practical and efficient tool for high-throughput molecular analysis of tissues that help to identify new diagnostic and prognostic markers. It also targets human cancers and has a range of potential applications in basic research, prognostic oncology, and drug discovery. The growing need for targeted treatments for various chronic diseases such as cancer, genetic diseases, and others has boosted the growth of the market.
Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/1213 .
Global Tissue Microarray Market – Competitive Landscape:
Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp and general electric.
Tissue Microarray Market Segmentation:
The global tissue microarray market is segmented on the basis of procedure, technology, application, and end user.
On the basis procedure, it is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.
On the basis of technology, it is segmented into DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.
On the basis of application, it is segmented into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization and sequencing bioinformatics.
On the basis of end user, it is segmented into pharmaceutical and biotechnological companies, research organization, and others.
The Americas dominates the global tissue microarray market owing to the presence of strong economic condition, huge development in healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, availability of skilled healthcare professional are boosting the growth of the market.
Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of cancer, and infectious diseases, changing lifestyle, increasing prevalence of cancer among geriatric population. As per Organization for Economic Co-operation and Development (OECD), the share of GDP to health spending in Germany was 11.0% in 2013, which was 10.8% in 2012, thus this factor also drives the growth of the market in this region. All these factors will drive the market growth in Europe.
Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and china are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer in developing countries will directly increase the demand for various diagnosis & treatment methods and it will boost the growth of the market.
The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more in healthcare domain and developing medical facilities, which will boost the market growth in this region.
Get Your Customized Report @ https://www.marketresearchfuture.com/enquiry/1213 .
Major TOC For Tissue Microarray Market Research Report – Global Forecast to 2023:
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
3 RESEARCH METHODOLOGY
3.1 Research Process
3.2 Market Size Estimation
3.2.1 Market Share Analysis
3.3 Forecast Model
4 MARKET DYNAMICS
4.1.1 Increasing Application In Drug Discovery
4.1.2 Increasing Prevalence Of Cancer
4.1.3 Increasing Advancements In Biotechnology And Pharmaceutical Companies
4.1.4 Increasing Demand For Cost-Effective And Accurate Diagnostic Methods
4.2.1 Tissue Microarray Is That It May Not Be Fruitful For Heterogeneous Cancers
LIST OF TABLES
TABLE 1 MERGER AND ACQUISITION LANDSCAPE
TABLE 2 GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION)
TABLE 3 GLOBAL TISSUE MICROARRAY MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2014-2023 (USD MILLION)
TABLE 4 GLOBAL TISSUE MICROARRAY MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION, BY REGION, 2014-2023 (USD MILLION)
Avail Prime Discount @ https://www.marketresearchfuture.com/check-discount/1213 .
LIST OF FIGURES
FIGURE 1 GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2016 (%)
FIGURE 2 GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2016 (%)
FIGURE 3 GLOBAL TISSUE MICROARRAY MARKET, BY APPLICATION, 2016 (%)
FIGURE 4 GLOBAL TISSUE MICROARRAY MARKET, BY END USER, 2016 (%)
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –